Skip to main content

CX Institutional

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1737089 AUBURN, IN

Position in REGN

as of Jun 30, 2026 · filed Jul 2, 2026
Position Value
$240,062
-$58,177 QoQ
Shares Held
385
-0.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#996
of 1,322 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CX Institutional holds $30,767,447 across 22 Biotechnology names. REGN ranks #9 (0.8% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in REGN

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $240,062 385
2026-03-31 $298,239 386
2025-12-31 $288,679 374
2025-09-30 $214,224 381
2025-06-30 $158,550 302
2025-03-31 $177,584 280
2024-12-31 $212,274 298
2024-09-30 $324,833 309
2024-06-30 $317,411 302
2024-03-31 $288,747 300
2023-12-31 $276,661 315
2023-09-30 $255,940 311
2023-06-30 $201,909 281
2023-03-31 $245,679 299
2022-12-31 $207,067 287
2022-06-30 $91,034 154
2021-09-30 $80,488 133
2021-06-30 $77,078 138
2021-03-31 $40,216 85
2020-12-31 $38,165 79
2020-09-30 $45,342 81
2020-06-30 $49,892 80
2020-03-31 $29,785 61